Class II · Moderate risk
Test Cypionate 200mg/Anastrozole 1.5mg/Dutasteride 1.5mg/Ml in Oil Injectable
Lack of assurance of sterility
Is Anastrozole recalled?
Yes — there is an active recall. 6 ongoing FDA recalls mention Anastrozole (54 total). Check the affected lots below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Anastrozole. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Anastrozole recalls on record
none so far in 2026; 54 on record, newest first
Class II · Moderate risk
Test Cypionate 200mg/Anastrozole 0.75mg/Dutasteride 1mg/Ml in Oil Injectable
Lack of assurance of sterility
Class II · Moderate risk
Test Cypionate 200mg/Anastrozole 0.5mg/Dutasteride 1mg/Ml in Oil Injectable
Lack of assurance of sterility
Class II · Moderate risk
Test Cypionate 200mg/Anastrozole 0.5mg/Dutasteride 1mg/Ml #2 Injectable
Lack of assurance of sterility
Class II · Moderate risk
Test Cypionate 200mg/Anastrozole 0.5mg/Dutasteride 1.5mg/Ml in Oil Injectable
Lack of assurance of sterility
Class II · Moderate risk
Test Cypionate 200mg/Anastrozole 0.5mg/Dutasteride 0.75mg/Ml in Oil Injectable
Lack of assurance of sterility
Class II · Moderate risk
Test Cypionate 200mg/Anastrozole 0.5mg/Dutasteride 0.5mg/Ml in Oil Injectable
Lack of assurance of sterility
Class II · Moderate risk
Test Cypionate 200mg/Anastrozole 0.25mg/Dutasteride 1mg/Ml in Oil Injectable
Lack of assurance of sterility
Class II · Moderate risk
Testosterone/Anastrozole Pellet 100/6 mg
Lack of Processing Controls (lack of assurance of conformity to specifications).
Class II · Moderate risk
Anastrozole Tablets
GMP Deviations: Potential cross contamination due to cleaning procedure failure.
Class II · Moderate risk
Anastrozole Tablets
GMP Deviations: Potential cross contamination due to cleaning procedure failure.
Class II · Moderate risk
Anastrozole Tablets
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Class II · Moderate risk
ANASTROZOLE Tablets
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Class II · Moderate risk
Testosterone 200 mg/Anastrozole 20 mg pellet
Lack of Assurance of Sterility
Class II · Moderate risk
Testosterone/Anastrozole 60 mg/4 mg pellets packaged in amber vial
Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.
Class II · Moderate risk
Testosterone/Anastrozole 60 mg/1 mg pellets packaged in amber vial
Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.
Class II · Moderate risk
Testosterone/Anastrozole 200 mg/20 mg pellets packaged in amber vial
Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.
Class II · Moderate risk
Testosterone/Finasteride/Anastrozole 120 mg/10 mg/4 mg pellet Amber vial
Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.
Class II · Moderate risk
Testosterone/Estradiol 60 mg/6 mg pellet Amber vial
Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.
Class II · Moderate risk
Testosterone/Anastrozole 120 mg/8 mg pellets packaged in amber vial
Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.
Class II · Moderate risk
Anastrozole USP for prescription compounding
CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.
Class II · Moderate risk
Anastrozole SR 1 mg Capsules
Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class II · Moderate risk
Anastrozole 0.5 mg Capsules
Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.
Class II · Moderate risk
Testosterone Cypionate/Anastrozole Injectable
Lack of Assurance of Sterility
Class II · Moderate risk
Testosterone 200 mg/Anastrozole 9 mg Pellet
Superpotent and Subpotent drugs
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.